STOCK TITAN

Clearside Biomedical, Inc. (CLSD) Free Cash Flow by Year

CLSD

Clearside Biomedical, Inc. recorded an outflow of $25.7M in free cash flow in fiscal year 2024. This represents a decrease of 28.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to an outflow of $21.7M in free cash flow. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Clearside Biomedical, Inc. has filed alongside them.

FY2024 annual
Free Cash Flow -$25.7M
YoY -28.9%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CLSD Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Free Cash Flow-$21.7M-$25.7M-28.9%-$19.9M-46.3%-$13.6M-26.8%-$10.7M+18.5%-$13.2M+51.4%-$27.1M+65.8%-$79.3M-54.3%-$51.4M-126.3%-$22.7M-63.0%-$13.9M-50.4%-$9.3M

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

CLSD Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'25Q4'2410-QQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23Q1'23Q4'22
Free Cash Flow-$5.5M+8.1%-$4.7M+22.5%-$5.8M+26.2%-$5.7M-1619.5%-$6.0M+8.5%-$6.1M+5.2%-$7.9M-7.9%$375K+106.6%-$6.5M-2.8%-$6.4M-18.2%-$7.3M-289.4%-$5.7M

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Clearside Biomedical, Inc. financials

Frequently Asked Questions

What was Clearside Biomedical, Inc.'s free cash flow in fiscal year 2024?

Clearside Biomedical, Inc. recorded an outflow of $25.7M in free cash flow in fiscal year 2024.

How fast is Clearside Biomedical, Inc.'s free cash flow growing?

Clearside Biomedical, Inc. (CLSD) free cash flow fell by 28.9% year over year, from -$19.9M to -$25.7M in fiscal year 2024.

What is Clearside Biomedical, Inc.'s free cash flow over the last twelve months?

Clearside Biomedical, Inc. (CLSD) reported an outflow of $21.7M in free cash flow over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, Clearside Biomedical, Inc. (CLSD) free cash flow went from -$9.3M in fiscal year 2014 to -$25.7M in fiscal year 2024.

Clearside Biomedical, Inc. (CLSD) reported -$5.5M in free cash flow in Q3 2025. This represents an increase of 8.1% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Clearside Biomedical, Inc. (CLSD) reported on that line in every period on record.